From pharmacology to immunopharmacology

British Journal of Clinical Pharmacology

Volumn 62, Issue 4, 2006, Pages 379-382

  Cohen, Adam ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; ETANERCEPT; NONSTEROID ANTIINFLAMMATORY AGENT; RAPAMYCIN;

ANGIONEUROTIC EDEMA; CLINICAL PHARMACOLOGY; CORTICOSTEROID THERAPY; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG RESEARCH; EDITORIAL; FOOD DRUG INTERACTION; HUMAN; IMMUNOPHARMACOLOGY; LUNG FUNCTION; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL SPECIALIST; PHARMACIST; PHARMACOEPIDEMIOLOGY; PHARMACOGENETICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSORIASIS; REGISTER; RESEARCH ETHICS; RISK REDUCTION;

DRUG DESIGN; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PHARMACOLOGY; TECHNOLOGY, PHARMACEUTICAL;

EID: 33748746829     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02760.x     Document Type: Editorial

References (24)

1. Beck KE, Blansfield JA, Tran KQ, Feldman AL, Hughes MS, Royal RE, Kammula US, Topalian SL, Sherry RM, Kleiner D, Quezado M, Lowy I, Yellin M, Rosenberg SA, Yang JC. Enterocolitis in patients with cancer after antibody blockade of cytotoxic T-lymphocyte-associated antigen 4. J Clin Oncol 2006; 24: 2283-9.
2. Blansfield JA, Beck KE, Tran K, Yang JC, Hughes MS, Kammula US, Royal RE, Topalian SL, Haworth LR, Levy C, Rosenberg SA, Sherry RM. Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer. J Immunother 2005; 28: 593-8.
3. Phan GQ, Yang JC, Sherry RM Hwu P, Topalian SL, Schwartzentruber DJ, Restifo NP, Haworth LR, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, Duray PH, Steinberg SM, Allison JP, Davis TA, Rosenberg SA. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA 2003; 100: 8372-7.
4. Weatherall M. In Search of a Cure. A History of Pharmaceutical Discovery. Oxford: Oxford University Press, 1990.
5. Dollery CT. Clinical pharmacology - the first 75 years and a view of the future. Br J Clin Pharmacol 2006; 61: 650-65.
6. Maxwell SR, Webb DJ. Clinical pharmacology - too young to die? Lancet 2006; 367:799-800.
7. Hollon T. Researchers and regulators reflect on first gene therapy death. Nat Med 2000; 6: 6.
8. Bhogal N, Combes R. An Update on TGN1412. Altern Lab Anim 2006; 34: 351-6.
9. Bhogal N, Combes R. TGN1412: time to change the paradigm for the testing of new pharmaceuticals. Altern Lab Anim 2006; 34: 225-39.
10. Farzaneh L, Kasahara N, Farzaneh F. The strange case of TGN1412. Cancer Immunol Immunother 2006 Jun 17; [Epub ahead of print].
11. Goodyear M. Learning from the TGN1412 trial. BMJ 2006; 332: 677-8.
12. Hansen S, Leslie RG. TGN1412: scrutinizing preclinical trials of antibody-based medicines. Nature 2006; 441: 282.
13. Schneider CK, Kalinke U, Lower J. TGN1412 - a regulator's perspective. Nat Biotechnol 2006; 24: 493-6.
14. Cohen AF, Kenter MJH. Determining risk in human experimentation with drugs. Lessons from TGN1412. Lancet 2006; in press.
15. Goodyear M. Learning from the TGN1412 trial. BMJ 2006; 332: 677-8.
16. Aronson JK. An Account of the Foxglove and its Medical Uses, 1785-1985. Oxford: Oxford University Press, 1985: 1.
17. Aarons L. Physiologically based pharmacokinetic modelling: a sound mechanistic basis is needed. Br J Clin Pharmacol 2005; 60: 581-3.
18. Schirm E, de Vries T, Tobi H, van den Berg P, De Jong-van Den Berg L. Prescribed doses of inhaled steroids in Dutch children: too little or too much, for too short a time. Br J Clin Pharmacol 2006; 62: 383-90.
19. Lavorini F, Geri P, Mariani C, Maluccio NM, Pistolesi M, Fontana GA. Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based upon functional antagonism. Br J Clin Pharmacol 2006; 62: 403-11.
20. Mortimer K, Harrison TW, Tang Y, Wu K, Lewis S, Sahasranaman S, Hochhaus G, Tattersfield A. Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma. Br J Clin Pharmacol 2006; 62: 412-9.
21. Dansirikul C, Morris RG, Tett SE, Duffull SB. A Bayesian approach for population pharmacokinetic modelling of sirolimus. Br J Clin Pharmacol 2006; 62: 420-34.
22. Nestorov I, Zitnik R, DeVries T, Nakamishi AM, Wang A, Banfield C. Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis. Br J Clin Pharmacol 2006; 62: 435-45.
23. Downing A, Jacobsen J, Toft Sorensen H, McLaughlin J K, Johnsen SP. Risk of hospitalisation for angio-oedema among users of newer COX-2 selective inhibitors and other non-steroidal ant-inflammatory drugs. Br J Clin Pharmacol 2006; 62: 496-501.
24. Sibille M, Donazzolo Y, Lecoz F, Krupka E. After the London tragedy, is it still possible to consider Phase I is safe? Br J Clin Pharmacol 2006; 62: 502-3.